Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06276933
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-26
First Post:
2024-02-16
Brief Title:
A Study of Camrelizumab Combined With Chemotherapy Thalidomide in First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Organization:
Tongji University